ADIAL PHARMACEUTICALS, INC. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Adial Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $19.7K, a 92.2% increase year-over-year.
  • Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$114K, a 280% decline from 2022.
  • Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $63.3K.
  • Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$229K, a 753% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$114K -$177K -280% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $63.3K +$292K Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$229K -$264K -753% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $35K +$382K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$347K +$4.3M +92.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 -$4.64M -$4.5M -3121% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 -$144K Jan 1, 2017 Dec 31, 2017 10-K 2019-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.